Reckitt Divests Dermicool To India's Emami
Reckitt will divest heat rash treatment Dermicool to India's Emami as it continues to reshape its portfolio around brands with higher growth potential.
Reckitt will divest heat rash treatment Dermicool to India's Emami as it continues to reshape its portfolio around brands with higher growth potential.